Trial shows muted impact of Paxlovid on healthier patients New data confirms limited efficacy for those at ‘standard risk’, with more positive results for higher risk cohorts.
ATAGI announces COVID booster program for some adolescents The advisory group has said 12–15-year-olds with specified underlying conditions should receive an additional vaccine dose.
No plans for fourth COVID-19 vaccine dose for GPs The Department of Health has indicated that healthcare workers are more at risk of getting COVID-19 in the community than at work.
Australia records fifth Japanese encephalitis death The latest confirmed death has prompted health authorities to remind GPs of their role in vaccination uptake.
Flu jab ‘helped workers avoid COVID-19’: Study A new pre-print article looking at healthworkers in Qatar suggests those who had a flu jab stood a much better chance of dodging severe COVID-19.
What do rising COVID-19 case numbers mean for GPs? Cases and deaths are many times the amount modelled ahead of Australia’s re-opening – although there has been surprisingly little discussion.
COVID-19 advice translated into 15 languages Information is now available through healthdirect in a variety of commonly spoken languages covering multiple aspects of managing the disease.
ATAGI updates post-infection vaccination advice The new recommendation reflects evidence that a longer gap between COVID-19 infection and vaccination will improve immune responses.
Decline in Australia’s COVID vaccine donations as wastage soars Untold numbers of Australian COVID-19 vaccines are ending up in the bin, when they could be going into the arms of the world’s most vulnerable.
COVID antiviral order doubled ahead of PBS listing Paxlovid will be available on the Pharmaceutical Benefits Scheme from May, with ‘really positive responses’ reported so far.